A contemporary survival analysis of individuals with cystic fibrosis: A cohort study

European Respiratory Journal

Volumn 45, Issue 3, 2015, Pages 670-679

  Stephenson, Anne L ^a,b,c,d   Tom, Melissa ^b   Berthiaume, Yves ^e   Singer, Lianne G ^d,f   Aaron, Shawn D ^g   Whitmore, G A ^g,h   Stanojevic, Sanja ^c,i  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^h MCGILL UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ARTICLE; BACTERIAL INFECTION; CANADIAN; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE REGISTRY; FACTORIAL ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RISK PATIENT; HUMAN; INFANT; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; NONHUMAN; PATIENT INFORMATION; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SURVIVAL; SURVIVAL TIME; AGE; CANADA; COMPLICATION; DISEASE COURSE; EPIDEMIOLOGY; INCIDENCE; LIFE EXPECTANCY; MIDDLE AGED; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER; RESPIRATORY TRACT INFECTIONS; SEX DIFFERENCE;

ADULT; AGE FACTORS; CANADA; CHILD; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; INFANT; LIFE EXPECTANCY; MALE; MALNUTRITION; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SEX FACTORS;

EID: 84923879579     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00119714     Document Type: Article

References (29)

1. Dodge JA, Lewis PA, Stanton M, et al. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007; 29: 522-526.
2. Slieker MG, Uiterwaal CSPM, Sinaasappel M, et al. Birth prevalence and survival in cystic fibrosis. Chest 2005; 128: 2309-2315.
3. Kerem E, Reisman J, Corey M, et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992; 326: 1187-1191.
4. Milla CE, Warwick WJ. Risk of death in cystic fibrosis patients with severely compromised lung function. Chest 1998; 113: 1230-1234.
5. Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005; 28: 2141-2144.
6. Aurora P, Wade A, Whitmore P, et al. A model for predicting life expectancy of children with cystic fibrosis. Eur Respir J 2000; 16: 1056-1060.
7. Kulich M, Rosenfeld M, Goss CH, et al. Improved survival among young patients with cystic fibrosis. J Pediatr 2003; 142: 631-636.
8. Rosenfeld M, Davis R, FitzSimmons S, et al. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997; 145: 794-803.
9. Liou TG, Adler FR, FitzSimmons SC, et al. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001; 153: 345-352.
10. Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011; 365: 1663-1672.
11. Fuchs HJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994; 331: 672-673.
12. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999; 340: 23-30.
13. Liou TG, Adler FR, Cahill BC, et al. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA 2001; 286: 2683-2689.
14. Moran A, Becker D, Casella SJ, et al. Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review. Diabetes Care 2010; 33: 2677-2683.
15. George PM, Banya W, Pareek N, et al. Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007. BMJ 2011; 342: d1008.
16. Nick JA, Chacon CS, Brayshaw SJ, et al. Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis. Am J Respir Crit Care Med 2010; 182: 614-626.
17. Cystic Fibrosis Canada. Annual Registry Report. Toronto, Cystic Fibrosis Canada, 2011.
18. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-187.
19. Wang X, Dockery DW, Wypij D, et al. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993; 15: 75-88.
20. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000; 314: 1-27.
21. World Health Organization. BMI Classification. Geneva, WHO, 2013.
22. Moran A, Hardin D, Rodman D, et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 1999; 45: 61-73.
23. Waters V, Atenafu EG, Lu A, et al. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients. J Cyst Fibros 2013; 12: 482-486.
24. Dasenbrook EC, Checkley W, Merlo CA, et al. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 2010; 303: 2386-2392.
25. de Boer K, Vandemheen KL, Tullis E, et al. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax 2011; 66: 680-685.
26. Waters V, Stanojevic S, Atenafu EG, et al. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis. Eur Respir J 2012; 40: 61-66.
27. Davis PB. The gender gap in cystic fibrosis survival. J Gend Specif Med 1999; 2: 47-51.
28. Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996; 143: 1007-1017.
29. Moran A, Dunitz J, Nathan B, et al. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009; 32: 1626-1631.